Medical Health & Life Science Research News

Europe's liver disease treatment market investment opportunities examined in new market research report

Europe Liver Disease Treatment Market is expected to reach USD 2.83 billion by 2021 from USD 2.77 billion in 2016, growing at a CAGR of 11.56% during the forecast period, 2016-2021.

As the second largest internal organ, liver performs many complex functions in the body (bile secretion, toxin removal, and fighting infections,.). Malfunctioning of liver can be life-threatening as it can cause multiple acute and chronic diseases (hepatitis, non-alcoholic fatty liver disease, liver cancer, liver tumour, and liver cirrhosis, among others).

The initial symptoms of liver damage include nausea, fatigue, diarrhoea, jaundice, swollen abdomen, and mental disorientation among other. Europe is among one of the leading market for Liver Disease Treatment Drugs.

As per a report, liver cirrhosis cause 170,000 deaths in Europe annually. Within Europe, Germany, France and United Kingdom accounts for largest share of liver disease treatment market.

View Full Report @…ment-market-1735/ Make an Inquiry about this news

The growth of Liver Disease Treatment market is majorly driven by factors such as boost in Research & Development investment, growth in geriatric population, and unmet needs for the treatment of liver cancer.  Europe is known for heavy drinking population in the world, therefore alcohol induced liver diseases is also responsible for spiking the demand for the product.

Also, growing obese population has also increased the risk of non-alcoholic fatty liver disease which is caused by build-up of fat in the liver. The key restraints of the market are complex drug approval procedure, side-effects of the product (fatigue, fever, and depression), and high cost incurred for product’s R&D process.

Free sample of the report is available @…35/request-sample Make an Inquiry about this news

Europe Liver Disease Treatment Market is segmented on the basis of Treatment Modality and Disease Type. Based on Treatment Modality, the market is classified into Antiviral, Vaccines, Chemotherapy, Immunosuppressive Agents, Corticosteroids, and Others.

On the basis of Disease Type, the market is classified into Hepatitis, Non-Alcoholic Fatty Liver Disease, Alcohol Induced, Liver Cancer, and Others.

The European market is geographically segmented into United Kingdom, Spain, Germany, Italy, and France. 

Inquire report @…rket-1735/inquire Make an Inquiry about this news

The major companies dominating the European Liver Disease Treatment Market are Gilead Science Inc. (U.S.), Pfizer Inc. (U.S.), Merck & Co.

(U.S.), Johnson & Johnson (U.S.), Novartis (Switzerland), Roche (Switzerland), Sanofi-Aventis (France), Abbott Laboratories (U.S.), Bayer Schering AG (Germany), and AstraZeneca (United Kingdom).

Scope of the Report

  • Regional and country-level analysisand forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysisin terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC)in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysisfor analysing the level of competition and business strategy development
  • A comprehensive list of key market playersalong with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysislisting out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunitiesto provide both individuals and organizations a strong financial foothold in the market

News From

Market Data Forecast - market research, business intelligence and consultingMarket Data Forecast
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
This email address is being protected from spambots. You need JavaScript enabled to view it.

For more information:

Make an Inquiry about this report HERE!